Author:
Shi Jinxin,Gao Peng,Song Yongxi,Chen Xiaowan,Li Yuan,Zhang Changwang,Wang Hongchi,Wang Zhenning
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108 (2015).
2. Buzzoni, R. et al. Pathological features as predictors of recurrence after radical resection of gastric cancer. Br J Surg 93, 205–9 (2006).
3. Liu, Y., Feng, Y., Gao, Y. & Hou, R. Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery. Onco Targets Ther 9, 1269–73 (2016).
4. Glimelius, B., Hoffman, K., Haglund, U., Nyren, O. & Sjoden, P. O. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol 5, 189–90 (1994).
5. Ochenduszko, S. et al. Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial. Med Oncol 32, 242 (2015).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献